10x Genomics
10x Genomics is a life science technology company based in Pleasanton, California, that specializes in developing instruments, consumables, and software for the analysis of biological systems. Founded in 2012, the company offers a range of products, including Chromium instruments, microfluidic chips, slides, reagents, and various consumable products. Its innovative single cell solutions enable researchers to assess gene expression, immune profiling, epigenetics, and cellular heterogeneity at an individual cell level. The Visium spatial gene expression solution allows for the analysis of gene expression patterns across tissue samples, providing valuable insights into biological processes. 10x Genomics serves a diverse client base, including academic institutions, government organizations, and biopharmaceutical companies across multiple regions, including North America, Europe, and Asia. The company generates the majority of its revenue from consumables, underscoring its focus on providing essential tools for genomic research.
Top Stages
6 past transactions
Tetramer Shop
Acquisition in 2021
Tetramer Shop is a developer of drug technology focused on MHC tetramers, which are utilized for the testing and monitoring of antigen-specific T cells. The company caters to a diverse clientele, including academic research institutions and therapeutic development laboratories, with particular emphasis on cancer vaccine development. By advancing the capabilities of MHC tetramers, Tetramer Shop plays a crucial role in enhancing research and therapeutic efforts in immunology and oncology.
ReadCoor
Acquisition in 2020
ReadCoor, Inc. is a technology company based in Cambridge, Massachusetts, specializing in the development and commercialization of a panomic spatial sequencing platform. The company offers the RC2 Platform, which utilizes proprietary Fluorescent in situ Sequencing (FISSEQ) technology to enable researchers, clinicians, and pharmaceutical and diagnostics companies to perform multi-omic analyses. This platform allows for the simultaneous detection and sequencing of numerous RNA, DNA, proteins, and therapeutics while visualizing sub-cellular nanoscale 3D resolution across tissue sections. By integrating high throughput sequencing with morphometric analysis and three-dimensional spatial imaging, ReadCoor provides valuable insights into human biology, facilitating the development of new therapeutics for various conditions, including cancer, infectious diseases, and neurological disorders. Founded in 2016, ReadCoor operates as a subsidiary of 10x Genomics, Inc. as of October 2020.
Cartana
Acquisition in 2020
Cartana AB is a biotechnology company based in Solna, Sweden, established in 2017. The company specializes in mapping gene expression in brain tissue using In Situ Sequencing (ISS), a cutting-edge technology that allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. Cartana's primary product, the NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section, providing high sensitivity and throughput for various research applications. The company also offers sequencing services that include sample preparation in their laboratory. By enabling detailed analysis of brain cells and other tissues, Cartana supports advancements in research, biomarker discovery, treatment validation, and potential diagnostic tools. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.
Cartana
Acquisition in 2020
Cartana AB is a biotechnology company based in Solna, Sweden, established in 2017. The company specializes in mapping gene expression in brain tissue using In Situ Sequencing (ISS), a cutting-edge technology that allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. Cartana's primary product, the NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section, providing high sensitivity and throughput for various research applications. The company also offers sequencing services that include sample preparation in their laboratory. By enabling detailed analysis of brain cells and other tissues, Cartana supports advancements in research, biomarker discovery, treatment validation, and potential diagnostic tools. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.
Spatial Transcriptomics
Acquisition in 2018
Spatial Transcriptomics AB is a life sciences company based in Stockholm, Sweden, that specializes in innovative technology for analyzing tissue samples and gene expression data in two dimensions. Founded in 2012, the company provides solutions that enable users to visualize and quantify gene expression within the histological context, facilitating comparisons of gene expression patterns and cellular characteristics. Its offerings include tissue optimization, library preparation, sequencing, and data visualization tools. Spatial Transcriptomics is particularly noted for its ability to perform RNA sequencing in two dimensions, which enhances the understanding of gene expression in various applications, including human and mouse studies. The company operates as a subsidiary of 10X Genomics, Inc., and has formed a strategic partnership with Seven Bridges to further advance its technological capabilities.
EPINOMICS
Acquisition in 2018
Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.